Proteus Biomedical, a biomedical technology company out of Redwood City, California, has been selected as one of this year’s World Technology Forum’s Technology Pioneers. The company develops MEMS
(microfabricated, multicomponent electronic components) devices for medical applications, small enough to be attached to pills to be used as “ingestible event markers”, as well as potential permanently embedded blood glucose monitoring chips. Back in March, we had a post about this company’s technology.
A statement by the company:
“Proteus has developed a unique approach to personalizing therapy,” said Andrew Thompson, Proteus CEO and co-founder. “We embed micro-sensors into existing drugs and devices, which transmit information, securely, to a person’s cell phone via the Internet. A person can understand how their body is responding to their therapy, and, if they choose, share this information with a family member, physician or friend to help them stay healthy. We are delighted that the World Economic Forum has recognized the immense potential of this approach and look forward to actively participating in their programs.”
Check out this video interview with Andrew Thompson:
Proteus Biomedical, Inc. …
Press release: Proteus Biomedical Honored by World Economic Forum …
More from SFgate.com: 5 Bay Area firms named 2009 Technology Pioneers…
Flashback: NextGen Pharmaceuticals: Pills That Talk, Sensors That Listen
